Fig. 4From: Potential role of PIM1 inhibition in the treatment of SARS-CoV-2 infectionExpression of TDG and SUMO1 after 24 h of SARS-CoV-2 infection in vitro. Expression levels are shown relative to control, with and without 2-pyridone PIM1 inhibitor treatmentBack to article page